Journal Metrics of Infection & Chemotherapy and Current Scholarly Journal Publication Issues

BACKGROUND: In 2013, Infection & Chemotherapy changed the main language of its articles to English so that they could be submitted to PubMed Central. This study presents the recent status of journal metrics for Infection & Chemotherapy and introduces scholarly journal publishing policies or guidelines that have recently appeared. MATERIALS AND METHODS: A variety of journal metrics were analyzed based on the Web of Science Core Collection, including the nationality of authors the proportion of funded articles to original articles , manually calculated impact factor, the titles of journals in which articles were cited”, and the Hirsch index. RESULTS: Out of 181 articles of Infection & Chemotherapy published between 2015 and 2018, the highest number of authors were from Korea (165, 91.2%). There were articles from 11 other countries. The proportion of funded articles to original articles has increased yearly and has reached 46.7% in 2018. The manually calculated impact factor of the year 2017 was 1.728, which corresponded to 21.5% of the 2017 Journal Citation Reports (JCR) category of “infectious diseases”. There were 196 source journal titles that cited Infection & Chemotherapy in the 2015–2018 issues. The Hirsch index was 15. CONCLUSION: The metrics results above demonstrate that over the years, Infection & Chemotherapy was developed into a top-level international-level journal so that it could be utilized by researchers across the world. The adoption of new policies including author taxonomy, an open data policy, a clinical data sharing policy, the principles of transparency and best practice in scholarly publishing 3rd edition will help increase the transparency of the authorship and the scientific integrity of the articles.